SCHEMBL8707140

SCHEMBL8707140

CN1C2CCCC1(OS(=O)(=O)C(F)(F)F)CC2

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.32
DRD1 P21728 2/20 0.32
DRD4 P21917 2/20 0.32
DRD5 P21918 2/20 0.32
DRD3 P35462 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4538423 0.71
SCHEMBL25228428 0.65
SCHEMBL9640284 0.63 CHRM2 (0.46)
SCHEMBL3161104 0.62
SCHEMBL3485175 0.62 DRD3 (0.42) DRD2DRD1DRD4DRD3
Hydrochloric Acid SCHEMBL4152474 0.61 DRD3 (0.41) DRD2DRD1DRD4DRD3
SCHEMBL7459966 0.60
SCHEMBL12192065 0.59 PTGS2 (0.31)
SCHEMBL15758249 0.58 SLC6A9 (0.30)
SCHEMBL19257936 0.58 SLC6A9 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828513-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1998-03-18 EP disclosed
WO-1996037226-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1996-11-28 WO disclosed